Aprea Therapeutics (APRE) Misses Q4 EPS by 49c

Aprea Therapeutics (NASDAQ: APRE) reported Q4 EPS of ($0.49). Revenue for the quarter came in at $210 thousand.

For earnings history and earnings-related data on Aprea Therapeutics (APRE) click here.

You May Also Be Interested In

• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Waymo wins California approval to expand ride-hailing service
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c